CTOR insider transaction filings
CITIUS ONCOLOGY, INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-12-22. Screen CTOR transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for CTOR between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — CITIUS ONCOLOGY, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-22 | 4/A | Smith Robert Joseph — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | Czuczman Myron — Chief Medical Officer | Grant/award (A): 825,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | Bartushak Jaime — Chief Financial Officer | Grant/award (A): 825,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | Holuka Eugene Myron — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | Webb Carol — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | Mayersohn Joel David — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | Dutia Suren G — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | Mazur Leonard L — Chief Executive Officer, Director | Grant/award (A): 1,700,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | MCGRATH DENNIS M — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-22 | 4/A | HOLUBIAK MYRON Z — Secretary, Director | Grant/award (A): 850,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Smith Robert Joseph — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Czuczman Myron — Chief Medical Officer | Grant/award (A): 825,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Bartushak Jaime — Chief Financial Officer | Grant/award (A): 825,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Holuka Eugene Myron — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Webb Carol — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Mayersohn Joel David — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Dutia Suren G — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | Mazur Leonard L — Chief Executive Officer, Director | Grant/award (A): 1,700,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | MCGRATH DENNIS M — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-12-01 | 4/A | HOLUBIAK MYRON Z — Secretary, Director | Grant/award (A): 850,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Smith Robert Joseph — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Czuczman Myron — Chief Medical Officer | Grant/award (A): 825,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Bartushak Jaime — Chief Financial Officer | Grant/award (A): 825,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Holuka Eugene Myron — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Webb Carol — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Mayersohn Joel David — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Dutia Suren G — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | Mazur Leonard L — Chief Executive Officer, Director | Grant/award (A): 1,700,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | MCGRATH DENNIS M — Director | Grant/award (A): 300,000 @ $0 | EDGAR |
| 2025-09-23 | 4 | HOLUBIAK MYRON Z — Secretary, Director | Grant/award (A): 850,000 @ $0 · Grant/award (A): 100,000 @ $0 | EDGAR |
| 2025-08-07 | 4 | Mayersohn Joel David — Director | Other (J): 21,228 @ $0 | EDGAR |
| 2024-12-16 | 4 | Smith Robert Joseph — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Czuczman Myron — Chief Medical Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Bartushak Jaime — Chief Financial Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Holuka Eugene Myron — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Webb Carol — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Mayersohn Joel David — Director | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Dutia Suren G — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Mazur Leonard L — Chief Executive Officer, Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | MCGRATH DENNIS M — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | HOLUBIAK MYRON Z — Secretary, Director | Grant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-08-30 | 4/A | Czuczman Myron — Chief Medical Officer | Grant/award (A): 1,400,000 (derivative) @ $0 | EDGAR |
| 2024-08-30 | 4/A | Bartushak Jaime — Chief Financial Officer | Grant/award (A): 1,400,000 (derivative) @ $0 | EDGAR |
| 2024-08-30 | 4/A | Mazur Leonard L — Chief Executive Officer, Director | Grant/award (A): 3,700,000 (derivative) @ $0 | EDGAR |
| 2024-08-30 | 4/A | HOLUBIAK MYRON Z — Director | Grant/award (A): 1,500,000 (derivative) @ $0 | EDGAR |
| 2024-08-16 | 4 | Holuka Eugene Myron — Director | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | Citius Pharmaceuticals, Inc. — 10% owner | Holdings only — no transactions reported | EDGAR |
| 2024-08-14 | 4 | Mazur Leonard L — Chief Executive Officer, Director | Grant/award (A): 1,233,333 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | MCGRATH DENNIS M — Director | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | HOLUBIAK MYRON Z — Director | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — CITIUS ONCOLOGY, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-28 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-03-31 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-10 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CTOR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →